VolitionRx Limited (VNRX) Earnings History
Net Loss22 years of earnings data (2004–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
VolitionRx Limited (VNRX) Earnings Overview
As of June 25, 2026, VolitionRx Limited (VNRX) reported trailing twelve-month net income of -$25M, reflecting +29.0% year-over-year growth. The company earned $-3.57 per diluted share over the past four quarters, with a net profit margin of -1352.2%.
Looking at the long-term picture, VNRX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$10,947 in fiscal 2010.
VolitionRx Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), ILMN ($853M net income, 19.6% margin), NTRA (-$226M net income, -9.0% margin), VNRX has room to improve margins relative to the peer group. Compare VNRX vs EXAS →
VNRX Earnings vs Peers
Earnings metrics vs comparable public companies
VNRX Historical Earnings Data (2004–2025)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$23M | +13.4% | -$21M | $-4.40 | -1352.2% | -1228.6% |
| 2024 | -$27M | +23.6% | -$27M | $-6.20 | -2186.3% | -2190.9% |
| 2023 | -$35M | -16.7% | -$36M | $-10.00 | -4555.5% | -4641.8% |
| 2022 | -$30M | -12.9% | -$32M | $-11.00 | -9879.1% | -10372.4% |
| 2021 | -$27M | -31.8% | -$28M | $-10.20 | -29782.5% | -31469.0% |
| 2020 | -$20M | -26.4% | -$21M | $-9.00 | -151508.3% | -158176.2% |
| 2019 | -$16M | +10.6% | -$16M | $-8.20 | -94168.5% | -93840.2% |
| 2018 | -$18M | -21.9% | -$18M | $-11.40 | - | - |
| 2017 | -$15M | -24.1% | -$15M | $-11.20 | - | - |
| 2016 | -$12M | -24.9% | -$12M | $-10.40 | - | - |
| 2015 | -$10M | -16.0% | -$10M | $-10.80 | - | - |
| 2014 | -$8M | -121.4% | -$6M | $-12.20 | -55553.1% | -40158.4% |
| 2013 | -$4M | +9.1% | -$5M | $-6.80 | - | - |
| 2012 | -$4M | -56.5% | -$4M | $-8.80 | -7428.0% | -7428.0% |
| 2011 | -$3M | -23728.1% | -$3M | $-9.00 | - | - |
| 2010 | $-10,947 | +30.8% | $-10,947 | $-0.10 | - | - |
| 2009 | $-15,816 | +27.5% | $-15,816 | $-0.14 | - | - |
| 2008 | $-21,803 | +17.1% | $-21,803 | $-0.19 | - | - |
| 2007 | $-26,295 | +28.9% | $-26,295 | $-0.23 | - | - |
| 2006 | $-36,987 | -182.2% | $-36,987 | $-0.34 | - | - |
| 2005 | $-13,105 | +45.8% | $-13,105 | $-0.20 | - | - |
| 2004 | $-24,180 | - | $-24,180 | $-0.37 | - | - |
Download Data
Export VNRX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
22+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VNRX — Frequently Asked Questions
Quick answers to the most common questions about buying VNRX stock.
What is VNRX earnings per share (EPS)?
VNRX trailing twelve-month (TTM) diluted EPS is $-3.57, reflecting +29.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2004 to 2025 is available in the table on this page.
What is VolitionRx Limited's net income?
VolitionRx Limited (VNRX) trailing twelve-month net income is $-25M as of 2025. Earnings grew +29.0% year-over-year.
Is VNRX profitable?
VNRX is not currently profitable on a TTM basis, reporting a net loss of $-25M. Net margin is -1352.2%. Investors should monitor for a return to profitability.
What is VNRX's earnings growth rate?
VNRX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2004 to 2025.
What are VNRX's profit margins?
VolitionRx Limited net profit margin is -1352.2%, operating margin is -1228.6%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is VNRX growing earnings?
Yes, VNRX earnings are accelerating — EPS growth of +29.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-25M. Earnings momentum is strengthening.
What was VNRX's best earnings year?
VolitionRx Limited's highest annual net income on record is $-10947.00, achieved in fiscal year 2010. Earnings history on this page spans 2004 to 2025 and includes all annual and quarterly figures.
What were VNRX's earnings last quarter?
VNRX's most recent reported quarter was Q1 2026. Net income was $-7M with diluted EPS of $-0.97. For a full breakdown of all quarters, see the quarterly earnings table on this page.